The briefing was sponsored by the Coalition for Excellence in Medication Monitoring, of which Ameritox is a founding member.
Harry Leider, MD, CMO at Ameritox, addressed more than 33 House and Senate offices. He emphasized the value of using tools like pain medication monitoring, which provides physicians with information necessary to make treatment decisions regarding prescriptions.
More Articles on Pain Management:
Myoscience Focused Cold Therapy Device Receives FDA Clearance
New York Pain Consultants Sees 20% Increase in Patients Post-Hurricane Sandy
Dr. Jung-Woo Ma Joins Tri-State Pain Institute in Pennsylvania
